Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17931 (
galectin-3
)
2,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Thioredoxin
(
Trx
) inhibited human HMEC-1 dermal microvascular endothelial cell capillary tubule forming capacity in a Matrigel based assay in vitro. Inhibition of capillary tubule formation was
Trx
catalytic site and thioredoxin reductase (TrxR) dependent, mediated at the Matrigel matrix level, and associated with a shift from morphological differentiation to continuous proliferation, with enhanced cell spreading resulting in eventual monolayer formation. Soluble complex carbohydrates, which inhibited capillary tubule formation on Matrigel without induction of cell spreading or monolayer formation, failed to impair
Trx
promotion of cell spreading and mono-layer formation, suggesting a shift away from carbohydrate-mediated cell/matrix adhesive interactions. Laminin peptides YIGRS and SIKVAV, which impaired tubule formation on Matrigel without inducing cell spreading or monolayer formation, partially impaired cell spreading upon
Trx
-treated Matrigel without restoring tubule formation, consistent with a potential role for laminin in
Trx
-mediated effects.
Trx
reduced laminin and destabilised laminin/
galectin-3
complexes within Matrigel. Native purified EHS Laminin (also containing
galectin-3
), but not recombinant
galectin-3
, restored HMEC-1 capillary tubule formation on
Trx
-treated Matrigel. These data highlight a novel deregulatory effect of extracellular
Trx
upon morphological capillary differentiation that appears to depend upon the reduction of laminin and destabilisation of its interaction with
galectin-3
, possibly leading to
galectin-3
neutralisation that shifts cell/matrix adhesive interactions away from being carbohydrate mediated and results in loss of proliferation-inhibiting and differentiation promoting cues from this tumor basement membrane matrix.
...
PMID:Thioredoxin inhibits microvascular endothelial capillary tubule formation. 1464 68